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Introduction: An increased prevalence of pathological electroencephalography (EEG)
signals has been reported in patients with borderline personality disorder (BPD). In
an elaborative case description of such a patient with intermittent rhythmic delta and
theta activity (IRDA/IRTA), the BPD symptoms where linked to the frequency of the
IRDAs/IRTAs and vanished with the IRDAs/IRTAs following anticonvulsive therapy. This
observation raised a question regarding the prevalence of such EEG abnormalities in
BPD patients. The aim of this retrospective study was to identify the frequency of EEG
abnormalities in a carefully analyzed psychiatric collective. Following earlier reports, we
hypothesized an increased prevalence of EEG abnormalities in BPD patients.
Participants and Methods: We recruited 96 consecutive patients with BPD from
the archive of a university clinic for psychiatry and psychotherapy, and compared the
prevalence of EEG abnormalities to those of 76 healthy controls subjects. The EEGs were
rated by three different blinded clinicians, including a consultant specializing in epilepsy
from the local epilepsy center.
Results: We found a significant increase in the prevalence of IRDAs and IRTAs in BPD
patients (14.6%) compared to the control subjects (3.9%; p = 0.020).
Discussion: In this blinded retrospective case-control study, we were able to confirm an
increased prevalence of pathological EEG findings (IRDAs/IRTAs only) in BPD patients.
The major limitation of this study is that the control group was not matched on age and
gender. Therefore, the results should be regarded as preliminary findings of an open
uncontrolled, retrospective study. Future research performing prospective, controlled
studies is needed to verify our findings and answer the question of whether such EEG
findings might predict a positive response to anticonvulsive pharmacological treatment.
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INTRODUCTION
Electroencephalography (EEG) represents a method by which
the functional integrity of the brain can be investigated with
high temporal, but poor spatial, resolution. The discovery of this
method by Hans Berger (Berger, 1969; Shipton, 1975) marks
the advent of modern biological psychiatry. This paper focuses
on EEG abnormalities in patients with Borderline Personality
Disorder (BPD).
The concept of BPD was developed in the 1970s and was
introduced as a specific diagnostic category in DSM-III in 1980
(Goldstein, 1983). It is characterized by the core features of
emotional instability, impulsivity, and instability of self-image
and interpersonal relationships (Lieb et al., 2004). Since, episodic
dissociative phenomena that are often related to very aversive
states of inner tension also belong to the features of BPD and
because this is reminiscent of complex partial epileptic seizures, a
pathophysiological link to epilepsy has been discussed in the past
(Harris et al., 2002; Williams et al., 2006; Tebartz van Elst et al.,
2011). Further, there has been discussion as to whether patients
with specific epilepsy syndromes such as juvenile myoclonic
epilepsymight develop BPD featuresmore often than people with
other forms of epilepsy or healthy controls (de Araujo Filho and
Yacubian, 2013).
Early EEG studies found an increased prevalence of generally
diffuse EEG pathology in BPD patients (De La Fuente et al., 1998;
Reeves et al., 2003). In a meta-analysis by Shelley et al. (2008), the
respective prevalence rates were estimated to be between 5.8 and
46%. However, most of the summarized studies were hampered
by methodological problems, the samples sizes were rather small
or the EEG ratings had not been done in a blinded way.
In this context, we recently published the case of a patient
with BPD and the EEG pathology of intermittent rhythmic
delta and theta activity (IRDA and IRTA) with very severe
dissociative states of inner tension and autoaggressive behavior.
Anticonvulsive treatment with valproate led to remission of
clinical symptoms and a significant reduction in the frequency
of IRTAs. Based on these observations, we have put forward the
hypothesis of “local area network inhibition” (LANI hypothesis),
which holds that non-ictal, paroxysmal neuronal activity (like
sharp waves, polyspikes, spike-wave complexes [SWCs], IRDAs,
IRTAs) induces inhibitory adaptation processes in local networks
in an attempt by the brain to maintain the excitatory-inhibitory
homeostasis of the affected networks. Rare and distributed
trigger activity may induce sub-threshold inhibition, which
can fade away without producing neuropsychiatric symptoms,
while frequent and focal trigger activity could eventually induce
supra-threshold LANI, which then results in neuropsychiatric
symptoms depending on the affected cerebral site or circuit
(Tebartz van Elst et al., 2011).
IRDAs were originally described by Cobb in 1945 (Cobb,
1945). According to the local distribution, IRDAs can be
categorized as frontal IRDAs (FIRDAs), temporal IRDAs
(TIRDAs), and occipital IRDAs (OIRDAs). Without any local
specification, it is appropriate to simply refer to IRDAs. They
are regarded as a pathological EEG pattern of unknown
pathophysiological significance (Brigo, 2011). Within the
framework of the LANI model, we hypothesized that IRDAs
may have the pathophysiological potential to induce adaptive
homeostatic processes, potentially leading to functional
alternations of the affected neuronal networks. This assumption
is, for example, supported by observations that such EEG
phenomena are linked to complex neuropsychiatric symptoms
in the context of limbic encephalitis (van Vliet et al., 2012) or to
symptoms of migraine (Kakisaka et al., 2014).
The LANI model could explain the pathophysiology of some
symptoms in a subgroup of patients with BPD (i.e., those who
present with EEG abnormalities like IRDAs or IRTAs). Onemight
put forward the hypothesis, that—as in the case mentioned above
(Tebartz van Elst et al., 2011)—such patients could well respond
to therapy with anticonvulsants. Following this line of thought,
it is remarkable that the therapeutic efficacy of anticonvulsants
in cases of BPD has been described for a number of different
substances (Bellino et al., 2005; Loew et al., 2006; Stoffers et al.,
2010; Vita et al., 2011; Ripoll, 2012). Given these considerations,
it is noteworthy that in clinical practice many patients with BPD
do not receive a diagnostic work-up that includes a thorough
EEG investigation. However, before calling for such laborious
procedures, it is important to clarify how often such EEG
phenomena can be expected in unselected patients with BPD.
Rationale for our Study
In our clinic, we have a ward that specializes in providing in-
patient treatment for BPD patients through employing dialectic
behavioral therapy (Lynch et al., 2007). Even though the focus
of this ward is psychotherapy, we traditionally perform EEG
analyses for all hospitalized patients of our clinic. The current
clinical study takes advantage of this fact in that it enables us to
retrospectively analyze the frequency of relevant EEG pathologies
in these patients. Thus, the aim of this retrospective study
was to clarify the frequency of EEG abnormalities (i.e., SWCs,
IRDAs, and IRTAs) in BPD patients. Based on the findings of
earlier studies (Shelley et al., 2008), we hypothesized an increased
prevalence of EEG abnormalities in BPD patients.
PARTICIPANTS AND METHODS
The study received approval from the Ethics Committee of the
University of Freiburg (EK-Fr 233/14).
Composition of the Patient Group
We included patients suffering from BPDwho had been admitted
to our hospital for in-patient treatment between 2001 and 2011.
Since visual, high-quality EEG analysis is very time consuming,
we were not able to include all datasets. In the absence of
reliable and expectable prevalence rates from earlier controlled
studies, we decided to adopt a pragmatic approach and included
the first 100 consecutive patients who fulfilled all inclusion
and exclusion criteria. Due to post-hoc information, we had to
exclude four BPD patients, which led to 96 BPD patients being
included.
The BPD patients were diagnosed according to the standards
of our specialized unit, i.e., the Borderline diagnosis was
established by senior consultant psychiatrists based on a detailed
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structured psychiatric interview (Structured Clinical Interview
for DSM-IV, SCID I and II; First et al., 1996, 1997) that integrated
common psychiatric and somatic differential diagnoses as well as
the patients’ medical histories. We included more female patients
(93 out of 96) because our in-patient treatment is especially
designed for female BPD patients.
Patients with known comorbid organic psychiatric disorders,
psychotic disorders, or other personality disorders were excluded
from the study. We also excluded patients with any neurological
disorder, a history of birth complications, febrile convulsions or
encephalitic disease in the past. A family history of epilepsy also
led to exclusion from our study. Antiepileptic medication can
reduce epileptic EEG patterns (Duncan, 1987) and so might lead
to the underestimation of EEG abnormalities, while clozapine is
known to be the most proconvulsive medication and can lead
to an overestimation of EEG abnormalities (Welch et al., 1994;
Meyer, 2004; Alper et al., 2007). Therefore, we also excluded
patients taking anticonvulsant medication or the proconvulsant
drug clozapine. For patients who received more than one EEG,
we selected the initial one for this study.
Composition of the Control Group
In our daily clinical practice, we do not analyze the EEGs of
healthy controls. Therefore, we included controls from an earlier,
large EEG study conducted in-house. Again, any psychiatric or
neurological diagnoses lead to exclusion. Nicotine consumption
was not an exclusion criterion. We were able to include all 76
datasets for which electronic records were available (Feige et al.,
2008). In addition, we compared the findings of our BPD sample
to figures from the literature. Based on published data, EEG
abnormalities in healthy controls who received neurological as
well as psychiatric assessments were found in about 0.5% of cases
(study of 13,658 trainee pilots; Gregory et al., 1993). For the
statistical analysis, we conservatively assumed EEG abnormalities
in 1% of the general population (Shelley et al., 2008).
EEG Reading and Classification
All EEGs were recorded using the international 10/20 system for
20min, including a hyperventilation phase of more than 3min,
which was used as a provocation method. Sintered Ag-AgCl
bridge electrode impedances were kept below 5 kOhm. Signals
were acquired using a Schwarzer 25-channel USB amplifier,
filtered between 0.07 and 100Hz, sampled with a rate of 256Hz
and continuously stored on disc for later analysis. Neurofile R©
software was used for visual EEG analysis following typical
clinical standards. Longitudinal rows were used as standard
montage. In cases of pathological findings in the bipolar
longitudinal rows, we correlated abnormalities with bipolar
transverse rows and reference electrodes. All EEGs were analyzed
by the same blinded trained expert rater (MF), who identified all
normal EEGs in a first step. The abnormal and all nebulous EEG
findings were reevaluated in a second step by a board certified
neurologist (SB). All EEGs that were deemed abnormal following
this second step were rated by a board certified consultant
epileptologist from the local university epilepsy center (DMA).
All raters were blinded throughout the diagnostic process. Final
diagnosis was established as a consensus diagnosis of all raters.
All abnormalities were documented (i.e., each IRDA, IRTA,
and SWC). Figure 1 shows an exemplary EEG with IRTA. To
define clear outcome criteria and to avoid the overestimation of
pathological EEGs based on diffuse slowing due to drowsiness
or hyperventilation, we took care to exclude such phenomena of
physiological slowing and did not rate any unclear EEG slowing
as a pathological phenomenon.
FIGURE 1 | Example of a clinical electroencephalogram (EEG) of a patient with borderline personality disorder. The X-axis illustrates intermittent rhythmic
theta activity (IRTA), and Y-axis shows a referential montage to the ears. FP, frontoparietal; A, ear; F, frontal; C, central; P, parietal; O, occipital; Cz, central zero; EKG,
electrocardiography.
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TABLE 1 | Demographic and clinical characteristics of borderline
personality disorder and control group.
Borderline personality
disorder (n = 96)
Control group
(n = 76)
Statistics
Age 27.0 ± 6.9 37.8 ± 10.8 t = −7.7,
df = 121.1,
p ≤ 0.001
Gender 93 F:3M 38 F:38M X2 = 51.3,
df = 1,
p ≤ 0.001
SCHOOL EDUCATION
No degree 4 (4.2%) Not available
Low degree 27 (28.1%) Not available
Medium degree 35 (36.5%) Not available
High degree 28 (29.2%) Not available
Unknown 2 (2.1%) Not available
PROFESSIONAL DEGREE
None/semiskilled 53 (55.2%) Not available
Vocational training 31 (32.3%) Not available
University degree 10 (10.4%) Not available
Unknown 2 (2.1%) Not available
MEDICATION
Medication on
discharge
55 (57.3%) Unmedicated
No medication 41 (42.7%) Unmedicated
ABNORMAL PSYCHOPATHOLOGICAL FINDINGS*
Attention and memory 50 (52.1%) Not inquired
Formal thought
disorder
18 (18.8%) Not inquired
Fear and compulsion 26 (27.1%) Not inquired
Affectivity 86 (89.6%) Not inquired
Energy and
psychomotor domain
51 (53.1%) Not inquired
Circadian rhythm 32 (33.3%) Not inquired
Suicidal tendency 17 (17.7%) Not inquired
PSYCHIATRIC COMORBIDITY
Psychiatric overall
comorbidity
60 (62.5%) Excluded
ADHD 29 (30.2%) Excluded
Major Depression Current: 25 (26%)
Remitted: 5 (5.2%)
Excluded
Eating disorder 11 (11.5%) Excluded
Adaptation disorder 4 (4.2%) Excluded
Others** 12 (12.5%) Excluded
*Documented on discharge; **Phobia (in 3 patients), alcohol abuse (3), obsessive
compulsive disorder (2), dysthymia (1), bipolar disorder (1), tic disorder (1), somatoform
disorder (1). F, female; M, male; ADHD, attention deficit hyperactivity disorder.
Demographic and Psychometric Data
All demographic and psychometric information was assessed
using our clinic’s electronic documentation system. This data
comprised demographic data, psychopathological symptoms
following the standardized AMDP system (Arbeitsgemeinschaft
für Methodik und Dokumentation in der Psychiatrie,
www.amdp.de), medical and psychiatric history, medication, and
social information. Only patients with complete documentation
were included.
Data Handling and Statistical Analysis
All EEG, demographic, and psychometric information was
carefully evaluated and entered into a data bank using the
Statistical Package for the Social Sciences (SPSS 20). Age was
compared using two-sided independent-sample t-tests, while
gender was analyzed using Pearson’s two-sided X2-test. The
prevalence of EEG abnormalities between groups was compared
using Pearson’s two-sided X2-test. We compared the prevalence
rates of the BPD patients with both our own and a historical
control group. Moreover, we compared age matched groups,
after the exclusion of the oldest control subjects. In addition, we
compared only female patients and female controls. To exclude
any effects of medication, we compared the unmedicated BPD
patients with the control group. A p < 0.05 served as the criterion
of significance.
RESULTS
Demographic Data
Table 1 summarizes the clinical and demographic data of our
patients and the control group. The BPD patients turned out to
be significantly younger than the members of the control group.
Also, since the control group was not specifically generated to
be matched with this study, it consisted of a significantly higher
number of male subjects.
Prevalence of EEG Abnormalities
Only IRDAs and IRTAs were found in the patient and control
groups. No patient showed clear-cut epileptiform potentials such
as sharp waves, polyspikes, or spike-wave complexes. Still, the
BPD patients demonstrated significantly higher rates of EEG
abnormalities (X2 = 5.4, df = 1, p = 0.020). When comparing
the rate of EEG abnormalities to the 1% estimated from figures
in the literature, this difference became even more significant
(X2 = 12.8, df = 1, p ≤ 0.001).
When comparing only unmedicated BPD patients (n = 41)
to all controls, we also found increased percentages of EEG
abnormalities (X2 = 4.3, df = 1, p = 0.038;Table 2). Comparing
only female BPD patients (n = 93, age: 27.1 ± 6.9) and female
controls (n = 38; age: 40.1 ± 11.7; page ≤ 0.001), we find
higher rates of EEG pathologies in the female patients (15.1 vs.
5.3% in the controls), showing a non-significant trend in the X2-
test (X2 = 2.4, df = 1, p = 0.120). Due to the small sample
size of male patients (n = 3), we have not compared the male
groups. After excluding the oldest controls, we analyzed the age
matched groups (96 BPD patients vs. 41 controls). Again, the
EEG pathologies were higher in the BPD group (14.6 vs. 7.3%
in the controls), which was not significant (X2 = 1.4, df = 1,
p = 0.237).
Clinical Characteristics of BPD Patients
with IRDAs/IRTAs
Table 3 summarizes the clinical characteristics of the 14 BPD
patients with EEG abnormalities. All patients were female
and suffered mostly from mental tension, self-injuries and
dissociative symptoms. Five patients had attempted suicide.
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TABLE 2 | EEG abnormalities in borderline personality disorder.
Borderline personality disorder (n = 96) Control group (n = 76) Statistics (Pearson-X2-test)
IRDAs/ IRTAs 14 (14.6%) 3 (3.9%) X2 = 5.4; df = 1;
p = 0.020
Unmedicated borderline personality
disorder group (n = 41)
Control group (n = 76)
IRDAs/ IRTAs 6 (14.6%) 3 (3.9%) X2 = 4.3; df = 1;
p = 0.038
Borderline personality disorder (n = 96) Historical control group (Gregory et al.,
1993; Shelley et al., 2008)
IRDAs/ IRTAs 14 (14.6%) 1% X2 = 12.8; df = 1;
p ≤ 0.001
IRDAs, intermittent rhythmic delta activity; IRTAs, intermittent rhythmic theta activity.
FIGURE 2 | The local area network inhibition (LANI) model as a potential paraepileptic pathomechanism (Tebartz van Elst et al., 2011; Tebartz van Elst
and Perlov, 2013). IRDA, intermittent rhythmic delta activity; IRTA, intermittent rhythmic theta activity.
Six out of 14 patients were unmedicated, while eight patients
were taking antidepressants. Depression was the most frequent
comorbidity in patients with IRDAs/IRTAs. Three patients had a
comorbid eating disorder.
DISCUSSION
The main result of our study is that, among the BPD patients,
there was a significant subgroup of 14.6% who displayed
clear-cut EEG abnormalities in terms of IRDAs and IRTAs.
In contrast to other studies, no epileptic patterns could be
detected. However, due to the not exactly matched control
group, our results should be regarded as only preliminary
findings.
Comparison with Previous Studies
Our finding is well within the range of EEG abnormalities in
BPD patients reported in the review by Shelley and colleagues
(5.8–46%; Shelley et al., 2008; Table 4). In our study, only IRDAs
and IRTAs were found, as in some previous studies involving
BPD patients (Snyder and Pitts, 1984; De La Fuente et al., 1998).
Snyder and Pitts (1984) found significantly more abnormalities
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TABLE 3 | Characterization of patients with IRDAs/IRTAs.
Nr. Patient characteristics Paroxysmal symptoms Comorbidity Medication EEG-abnormalities
1 21 years, female, trainee
nurse
Dissociative symptoms, self
injuries, suicidal tendency,
several suicidal attempts
Depression,
PTSD
None IRDAs with frontal maximum
2 26 years, female, industrial
clerk
Mental tension, difficulties
controlling anger, self injuries,
several suicidal attempts
Atypical bulimia
nervosa
None IRDAs with frontal maximum
3 28 years, female,
commercial clerk
Affective instability, self injuries Depression
(currently remitted)
Citalopram FIRTAs
4 22 years, female, media
worker
Mental tension, self injuries,
affective instability
None None IRTAs
5 19 years, female, no
professional training
Mental tension, self injuries,
dissociative symptoms, suicidal
tendency, one suicidal attempt
Past alcohol abuse None IRTAs with fronto-central
maximum
6 19 years, female, school for
domestic science
Dissociative seizures, mental
tension, self injuries
None None IRTAs
7 22 years, female, no
professional training
Mental tension, self injuries Mild depression,
past substance
abuse, two suicidal
attempts
Venlafaxine IRDAs with frontal maximum
8 25 years, female, no
professional training
Dissociative states, mental
tension, self injuries, three
suicidal attempts
Anorexia nervosa,
depression
Quetiapine,
fluoxetine,
benperidol
IRTAs with parieto-temporal
maximum
9 22 years, female, trainee
office clerk
Mental tension, self injuries,
suicidal tendency, several
suicidal attempts
Depression
(currently remitted)
Venlafaxine,
prothipendyl,
chlorprothixene
FIRTAs
10 19 years, female, trainee
hotel clerk
Mental tension, self injuries None None FIRTAs
11 26 years, female, insurance
clerk
Dissociative states, mental
tension, suicidal tendency
Depression, ADHD,
PTSD
Methylphenidate,
fluspirilene
FIRTAs
12 25 years, female, insurance
clerk
Mental tension, self injuries,
dissociative states with
depersonalization and
derealization, suicidal tendency
Atypical bulimia
nervosa, depression
(currently remitted)
Citalopram,
perazine
FIRTAs
13 34 years, female, profession
unclear
Mental tension, self injuries,
derealization, hallucinations
None Risperidone,
zopiclone,
chlorprothixene,
fluoxetine,
tetrazepam
FIRTAs
14 27 years, female, office clerk Dissociative symptoms, mental
tension, self injuries, suicidal
tendency
ADHD, abuse of
alcohol
Venlafaxine,
zopiclone
FIRTAs
EEG, electroencephalogram; PTSD, Post-Traumatic Stress Disorder; ADHD, attention deficit hyperactivity disorder; IRDA, intermittent rhythmic delta activity; IRTA, intermittent rhythmic
theta activity; FIRTA, frontal intermittent rhythmic theta activity.
in 37 male BPD patients, mostly slow wave activity. De La Fuente
et al. (1998) described diffuse slow activity in 40% of the mostly
female patients in a collective of 20 patients. In a study by
Archer et al. (1988), dysrhythmia was found in 31.3%, while in
a study by Cornelius et al. (1986) it was detected in 18.8% of
the BPD patients. Ogiso et al. (1993) depicted an association
between positive spikes and high impulsivity. Our low overall
prevalence rates might be explained by our strict inclusion and
exclusion criteria, which excluded all patients with any evidence
of organic comorbidities and relevant medication effects. Also,
due to our desire to avoid an overestimation of pathological EEG
and in contrast to many other studies in the literature, we did not
rate unclear EEG slowing as pathological phenomena. Moreover,
differences in the reference electrodes in earlier studies might
have influenced the analysis process and findings.
Pathological EEG findings in Healthy
Subjects
In order to judge whether or not such findings are relevant, it is
important to clarify how often similar pathological EEG findings
are obtained in the general population without BPD. Depending
on the inclusion and exclusion criteria, EEG abnormalities were
identified in 0.3–18.6%, showing a broad range of “normality”
(Gregory et al., 1993; Boutros et al., 2005; Shelley et al., 2008).
However, after the exclusion of possible contaminating factors,
epileptiform dysrhythmia in healthy control groups can be
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TABLE 4 | Previous EEG findings in borderline personality disorder (following Boutros et al., 2003; Shelley et al., 2008).
Study N (PBD/ controls) Gender patients
(F/M)
Medication Comorbidity EEG-abnormalities Characteristics
Tebartz van Elst
et al., 2011
1/0 1/0 None None Epileptiform discharges Remission with
valporate
De La Fuente
et al., 1998
20/0 15/5 None None current Diffuse slow activity in
40%
More frequent in
medicated patients
Ogiso et al., 1993 18/21 18/0 Anxiolytics,
antipsychotics,
antidepressants
Depression, substance
abuse
Positive spikes in
patients with high
impulsivity;
Wave and spike
phantoms in patients
with interpersonal
relationship dysfunction
Drake et al., 1992 6/0 Not reported Not reported Not reported Normal findings in
patients
with pseudo-seizures
Schmid et al.,
1989
1/0 1/0 Antidepressant,
antipsychotic
Depression Normal
Cowdry et al.,
1985
39/20 (unipolar depressed
patients)
36/3 Not reported No current Axis I disorder,
Axis II not reported
More frequent
epileptiform discharges
in BPD; mostly
paroxysmal posterior
sharp waves
Messner, 1986 1/0 0/1 None None Focal temporal lobe
slow-wave activity
Archer et al., 1988 16/83 (10 with non-BPD
personality
disorders, 39 with
dysthymic disorders, 34
with other mixed
diagnosis)
Not reported None None Dysrhytmics in 31.3%;
6.3% had spike and
wave
discharges
No significant
differences compared
with control groups;
wake and sleep EEG
Cornelius et al.,
1986
69/22 (non-BPD
personality
disorders)
52/17 None None current Dysrhythmias
in 18.8% of BPD
patients; severe
abnormalities in 5.8%
No significant
differences compared
with non-BPD
personality disorder
group
Snyder and Pitts,
1984
37/31 (dysthymic disorder) 0/37 None None Significantly more
abnormalities, mostly
slow-wave activity
Only male patients
BPD, borderline personality disorder; F, female; M, male; EEG, electroencephalogram.
assumed to account for less than 1% of cases (Shelley et al.,
2008). Therefore, the authors of review articles regarding EEG
abnormalities in control groups and in psychiatric collectives
argue for stricter inclusion and exclusion criteria, such as those
enforced in our study (Boutros et al., 2005; Shelley et al., 2008).
Limitations
The major limitation of this study is that it is a retrospective
analysis without adequate control group. Therefore, the results
should basically be regarded as preliminary findings of an open
uncontrolled study and statistical calculations should be regarded
as only exploratory in nature. We cannot be sure about what is
driving the difference in occurrence of EEG abnormalities in this
sample. In any retrospective analysis of EEG patient collectives,
it is difficult to generate suitable control groups because controls
are not routinely investigated. Therefore, further and prospective
studies are needed to confirm the findings raised in this paper.
For this study, we were able to use a control group of healthy
participants who took part in an earlier project involving sleep
research (Feige et al., 2008). However, this control group was
smaller than our patient group and was not well matched with
respect to gender and age. The BPD patients were younger
than the controls and females were more common than in the
control group. The control subjects did not receive a thorough
neurological or psychiatric assessment. Earlier evidence from
basic clinical EEG research illustrates that the less strictly the
EEG control samples were defined in terms of neurological
and psychiatric evaluations, the higher the resulting prevalence
of EEG pathologies turned out to be (Tebartz van Elst and
Perlov, 2013). In large cohorts of well investigated pilots who
had received not only neurological but also internistic and
psychiatric evaluations, pathological EEGs proved to be very
rare, with a prevalence of between 0.3 and 0.6% (Thorner, 1942;
Bennett, 1967; Gregory et al., 1993). In contrast, less well defined
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control samples produced prevalence figures for pathological
EEG findings in 5–8% of cases (Iida et al., 1985; Okubo et al.,
1993). In that sense, our control sample is comparable to the
clinical samples published by Iida et al. (1985) and Okubo et al.
(1993), with pathological findings in 3.9% of cases. Therefore, we
would have detected false positive EEG pathologies in our control
group.
Moreover, the effect of medication could not be completely
eliminated since we were unable to include only unmedicated
patients. We excluded patients who were currently taking the
most proconvulsive (clozapine; Duncan, 1987; Meyer, 2004;
Alper et al., 2007) and typical anticonvulsive medications
(antiepileptics). However, other neuroleptics or antidepressants
might have influenced our results. Neuroleptics (e.g., olanzapine)
could reduce the seizure threshold to a lesser extent compared
with clozapine; some antidepressants—mainly selective
serotonin reuptake inhibitors—might have the opposite
effect and actually increase the seizure threshold (Alper et al.,
2007; Tebartz van Elst and Perlov, 2013).
However, six of the 14 BPD patients with pathological EEGs
were unmedicated and nine were medicated. A total of 41 out
of the 96 BPD patients were unmedicated. When restricting
the analysis to these 41 unmedicated patients and comparing
EEG abnormalities with our control group, the prevalence of
pathological EEG findings was the same (14.6%). This means that
our overall prevalence rates cannot be explained by a medication
effect.
Following clinical practice, the data analysis was performed
based on clinical expert ratings and was thus investigator-
dependent. Therefore, this kind of clinical data analysis is prone
to rater bias. For that reason, all clinical raters were blinded
with respect to the identity of the EEGs of interest. For this
reason, we can reject the suggestion that a rating bias might have
increased the prevalence of pathological EEG findings in our BPD
group.
Further, all EEGs deemed to be pathological were ultimately
assessed by a team of three experts, including one board certified
consultant neurologist (SB) and another very experienced board
certified consultant neurologist and epileptologist from the local
university epilepsy center (DMA). Therefore, we think that the
quality of the clinical rating of the EEGs corresponds to the
highest clinical standards. However, since the first line trained
rater (MF) is not an experienced epileptologist, we cannot rule
out the fact that false negative EEG ratings might have lowered
the prevalence of pathological EEG findings. In further studies,
an automatic and quantitative means of detecting IRDAs and
IRTAs should be performed to verify our results.
The sample size could have been larger than the 96 patients
we decided to include in this project. However, since visual EEG
analysis in general and the algorithm of analysis we chose in this
study in particular is extremely time consuming, for practical
reasons we were not able to create a larger sample. Also, the size
of our sample compares well to publications in the literature, as
can be deduced from Table 4.
The way we defined our sample does have an impact on
the generalizability of our findings. In order to avoid an
overestimation of the rate of EEG pathologies, we excluded
patients with any kind of neurological comorbidity as well as
those with a history of birth complications, febrile seizures,
a history of meningitis, or encephalitis, and a family history
of epilepsy. All of these factors could have contributed to
pathological EEG findings and were therefore excluded. We were
not able to exclude a medication effect in the overall sample
but, as mentioned above, the rate of EEG pathologies in the
unmedicated BPD patients was the same as that in the mixed
group. Since in the general medical settings quite a few BPD
patients do fulfill at least one of the exclusion criteria mentioned
above, we cannot generalize our findings to this clinical sample.
Also, in order to simulate the classical clinical diagnostic
setting, we assessed only routine EEG studies of 20min length.
Repeated and prospective EEG studies, including sleep and sleep
deprivation recordings, would most likely have produced higher
prevalence rates of pathological findings, possibly including
classical epileptiform activity. Therefore, our detection rate of
EEG abnormalities has to be regarded as a minimum detection
rate and it is very likely that the prevalence of pathological EEG
findings will be even higher if such exclusion criteria are not
applied or repeated and more elaborate assessment methods are
applied.
Despite these limitations, we here present the largest study
to date into possible EEG pathologies in BPD patients and
produce evidence that a considerable subgroup of 14.6% of BPD
patients do display EEG pathologies in terms of IRDAs or IRTAs.
Thus, a question arises as to what this might mean from a
pathophysiological point of view and with respect to treatment.
Clinical Relevance of IRDAs/IRTAs in BPD
The clinical relevance of intermittent rhythmic delta or theta EEG
activity is poorly understood. As discussed in the introduction,
both IRDAs and IRTAs are clearly regarded as pathological
EEG patterns (Brigo, 2011). However, it is unclear precisely
what their presence means in terms of disturbed neuronal
information processing. Clearly, none of our patients do suffer
from epilepsy. The LANI hypothesis outlined in the introduction
is a pathophysiological model that can explain why patients
exhibiting IRDAs or IRTAsmay develop clinical neuropsychiatric
symptoms at one time (i.e., when IRDAs are focal and frequent
enough to stimulate above threshold reactive neuronal network
inhibition) but not at another time (i.e., when IRDAs are
distributed or rare so that reactive neuromodulation remains
subthreshold and can fade away before another IRDA event
occurs) (Tebartz van Elst et al., 2011). If true, the IRDA/IRTA
model would be a model of a paraepileptic pathomechanism,
i.e., a pathophysiology in which non-ictal, but paroxysmal
EEG activity results in neuropsychiatric symptoms via reactive
network modulation (Figure 2). It is important to stress that
this assumed mechanism cannot be regarded as epilepsy
(Tebartz van Elst et al., 2011). Another well-established example
of such a paraepileptic pathomechanism is that of Todd’s
paresis (Fisher and Schachter, 2000), where epileptic seizure
activity also induces neuromodulatory processes that result in
long-term functional alterations of the neurophysiology and
affected neuronal networks (Fisher and Schachter, 2000; Schulze-
Bonhage and Tebartz van Elst, 2010; Tebartz van Elst et al., 2011).
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However, in Todd’s paresis the diagnosis is necessarily linked to
classical seizures whereas the LANI hypothesis is based on non-
ictal paroxysmal activity acting as the trigger mechanism, which
means that a diagnosis of epilepsy cannot be made (Tebartz van
Elst et al., 2011).
The idea that non-ictal epileptiform activity in the brain
causes secondary modulation of the neurophysiology of neuronal
networks, which in turn causes psychiatric symptoms, is not new
to neuropsychiatry (Stevens, 1988, 1995, 1999; Bruton et al., 1994;
Heimer, 2000, 2003; Tatlidil, 2000; Läppchen et al., 2008, 2011).
Such models are difficult to prove and the present study was a
first step in that direction as it validated the prevalence of the
EEG phenomenon of IRDAs or IRTAs in a fairly typical sample of
BPD patients in the tertiary referral setting of a specialized center
offering specific therapy.
At the end of the day, the question of the precise
pathophysiology and meaning of IRDAs and IRTAs is a rather
academic matter and it will take a while until we are able to
clarify it. However, from a clinical point of view, another more
important therapeutic question arises, i.e., whether or not the
observation of such EEG pathologies in BPD patients might have
therapeutic implications. We recently described a patient with
IRTAs and severe dissociative and auto-aggressive symptoms
who responded very well to therapy with valproate as well as
topiramate later in the course (Tebartz van Elst et al., 2011). Based
on this observation, one might speculate that the presence of
IRDAs or IRTAs in BPD patients might be a biological predictor
of a positive response to anticonvulsive treatment options. To
our knowledge, there are no studies published in the literature
focusing on this question. However, the answer to this question
might be very important for the therapy of a subgroup of
BPD patients. Clearly, further research is needed to resolve this
important clinical issue.
SUMMARY
To our knowledge, this uncontrolled study is the largest survey to
date on the prevalence of EEG pathology in a carefully selected,
retrospectively defined sample of BPD patients where all possible
risk factors for pathological EEG findings led to exclusion. The
EEG readings followed high standards and were conducted by
blinded highly qualified raters. We found a prevalence of IRDAs
or IRTAs in 14.6% of BPD patients. Further research is needed
to clarify whether or not such pathological EEG findings might
predict the response to anticonvulsive pharmacotherapy in these
patients.
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